Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma

Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma

Accumulating evidence shows a close association between various types of bile acids (BAs) and hepatocellular carcinoma (HCC), and they have been revealed to affect tumor immune response and progression mainly by regulating Farnesoid X receptor (FXR). Nevertheless, the roles of Norcholic acid(NorCA)...

Full description

Bibliographic Details
Main Authors:	Yihang Gong, Kun Li, Yunfei Qin, Kaining Zeng, Jianrong Liu, Shaozhuo Huang, Yewu Chen, Haoyuan Yu, Wei Liu, Linsen Ye, Yang Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma (HCC) bile acids exosomes immune microenvironment Farnesoid X receptor
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.711448/full

Similar Items

The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis
by: Dong Xiang, et al.
Published: (2023-12-01)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
by: Hideki Mori, et al.
Published: (2022-07-01)

Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
by: Joana Torres, et al.
Published: (2017-10-01)

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
by: Peijie Wu, et al.
Published: (2021-12-01)

Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
by: Shan Cao, et al.
Published: (2021-04-01)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
by: Sharon Manley, et al.
Published: (2015-03-01)

Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization
by: Suhang Guo, et al.
Published: (2022-03-01)

Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling
by: Ines L. Paraiso, et al.
Published: (2021-04-01)

Mesenchymal Stromal Cells Overexpressing Farnesoid X Receptor Exert Cardioprotective Effects Against Acute Ischemic Heart Injury by Binding Endogenous Bile Acids
by: Yunlong Xia, et al.
Published: (2022-08-01)

The Status of Bile Acids and Farnesoid X Receptor in Brain and Liver of Rats with Thioacetamide-Induced Acute Liver Failure
by: Anna Maria Czarnecka, et al.
Published: (2020-10-01)

Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats
by: Rulin Wang, et al.
Published: (2022-11-01)

Bile Acids and Their Value for Central Nervous System
by: Yu. O. Shulpekova, et al.
Published: (2022-01-01)

Bile duct ligation differently regulates protein expressions of organic cation transporters in intestine, liver and kidney of rats through activation of farnesoid X receptor by cholate and bilirubin
by: Shijin Hong, et al.
Published: (2023-01-01)

(E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like Peptide-1 Secretion From Enteroendocrine Cells
by: Alzbeta Stefela, et al.
Published: (2021-08-01)

Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
by: Limin Zhang, et al.
Published: (2016-10-01)

Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway
by: Xiaowei Sun, et al.
Published: (2023-05-01)

Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease
by: Silvia Marchianò, et al.
Published: (2023-12-01)

Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
by: Sun-Gi Kim, et al.
Published: (2016-12-01)

3D-QSAR and Molecular Dynamics Study of Isoxazole Derivatives to Identify the Structural Requirements for Farnesoid X Receptor (FXR) Agonists
by: Dan Yan, et al.
Published: (2024-03-01)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
by: Jianglian She, et al.
Published: (2022-01-01)

Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA
by: Longying Jiang, et al.
Published: (2023-01-01)

Stimulation of the farnesoid X receptor promotes M2 macrophage polarization
by: Thiranut Jaroonwitchawan, et al.
Published: (2023-01-01)

Importance of gut microbiota for bile acid composition and concentration in pigs
by: Jing Sun, et al.
Published: (2022-08-01)

Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
by: Guodong Li, et al.
Published: (2015-03-01)

Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting Fxr transcription, leading to cholestasis
by: Yihang Dai, et al.
Published: (2023-03-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
by: Apollinariya V. Bogolyubova, et al.
Published: (2017-12-01)

Farnesoid X receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice
by: Hui-Min Shan, et al.
Published: (2020-05-01)

Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway
by: Yang Fan, et al.
Published: (2023-11-01)

The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity
by: Magdalena Rausch, et al.
Published: (2022-11-01)

Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
by: Hongshan Li, et al.
Published: (2022-08-01)

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet
by: Payel Kundu, et al.
Published: (2022-11-01)

Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through Farnesoid X receptor/β-catenin signaling pathway
by: Shu Feng, et al.
Published: (2022-08-01)

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis
by: Michael Trauner, et al.
Published: (2023-03-01)

Mangrove Tirucallane- and Apotirucallane-Type Triterpenoids: Structure Diversity of the C-17 Side-Chain and Natural Agonists of Human Farnesoid/Pregnane–X–Receptor
by: Zhong-Ping Jiang, et al.
Published: (2018-12-01)

Farnesoid X Receptor Agonist GW4064 Protects Lipopolysaccharide-Induced Intestinal Epithelial Barrier Function and Colorectal Tumorigenesis Signaling through the αKlotho/βKlotho/FGFs Pathways in Mice
by: Hsuan-Miao Liu, et al.
Published: (2023-11-01)

Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity
by: Vahid Jamshidi, et al.
Published: (2021-11-01)

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension
by: John D. Imig
Published: (2023-06-01)

Dexamethasone induces an imbalanced fetal-placental-maternal bile acid circulation: involvement of placental transporters
by: Wen Huang, et al.
Published: (2021-04-01)

TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
by: Berggren-Söderlund Maria, et al.
Published: (2011-11-01)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
by: Yuxiang Qiu, et al.
Published: (2023-09-01)